 Melissa Mahoney
Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethylene Glycols | 17 | 2015 | 561 | 3.340 |
Why?
| | Neurons | 13 | 2011 | 1277 | 1.750 |
Why?
| | Tissue Engineering | 9 | 2014 | 364 | 1.480 |
Why?
| | Biocompatible Materials | 8 | 2014 | 372 | 1.460 |
Why?
| | Hydrogels | 9 | 2015 | 573 | 1.370 |
Why?
| | Embryonic Stem Cells | 4 | 2010 | 106 | 1.230 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 4 | 2011 | 72 | 1.110 |
Why?
| | Interleukin-10 | 5 | 2016 | 293 | 1.070 |
Why?
| | Cell Culture Techniques | 10 | 2015 | 341 | 0.950 |
Why?
| | Rats | 25 | 2016 | 4913 | 0.860 |
Why?
| | Lactic Acid | 6 | 2012 | 272 | 0.850 |
Why?
| | Neuroglia | 5 | 2011 | 149 | 0.790 |
Why?
| | Fibrin | 2 | 2010 | 63 | 0.680 |
Why?
| | Cell Survival | 8 | 2015 | 1014 | 0.670 |
Why?
| | Cell Differentiation | 8 | 2010 | 1696 | 0.670 |
Why?
| | Spinal Cord | 2 | 2012 | 344 | 0.620 |
Why?
| | Insulin-Secreting Cells | 3 | 2014 | 317 | 0.580 |
Why?
| | Cells, Cultured | 12 | 2011 | 3861 | 0.560 |
Why?
| | Brain-Derived Neurotrophic Factor | 4 | 2011 | 106 | 0.550 |
Why?
| | Genetic Therapy | 5 | 2016 | 256 | 0.550 |
Why?
| | Rats, Sprague-Dawley | 10 | 2011 | 2182 | 0.530 |
Why?
| | Brain | 6 | 2011 | 2355 | 0.530 |
Why?
| | Cell Proliferation | 8 | 2010 | 2173 | 0.520 |
Why?
| | Neuralgia | 2 | 2016 | 122 | 0.470 |
Why?
| | Drug Delivery Systems | 4 | 2010 | 295 | 0.470 |
Why?
| | Collagen | 2 | 2007 | 414 | 0.460 |
Why?
| | Animals | 31 | 2016 | 31565 | 0.430 |
Why?
| | Nerve Tissue | 3 | 2009 | 7 | 0.410 |
Why?
| | Pancreas | 2 | 2015 | 276 | 0.390 |
Why?
| | Injections, Spinal | 5 | 2016 | 101 | 0.370 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 924 | 0.370 |
Why?
| | Fibroblast Growth Factor 2 | 2 | 2011 | 82 | 0.370 |
Why?
| | Fetus | 3 | 2006 | 698 | 0.350 |
Why?
| | Brain Tissue Transplantation | 3 | 1999 | 19 | 0.340 |
Why?
| | Microscopy, Confocal | 5 | 2015 | 304 | 0.340 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2010 | 72 | 0.340 |
Why?
| | Gene Transfer Techniques | 2 | 2010 | 147 | 0.340 |
Why?
| | DNA | 4 | 2010 | 1350 | 0.330 |
Why?
| | Fibrinogen | 1 | 2010 | 143 | 0.330 |
Why?
| | Thrombin | 1 | 2010 | 129 | 0.330 |
Why?
| | Free Radical Scavengers | 1 | 2009 | 78 | 0.330 |
Why?
| | Free Radicals | 1 | 2009 | 99 | 0.320 |
Why?
| | Collagen Type I | 1 | 2009 | 108 | 0.320 |
Why?
| | Neovascularization, Physiologic | 1 | 2010 | 174 | 0.320 |
Why?
| | Guided Tissue Regeneration | 1 | 2009 | 13 | 0.320 |
Why?
| | Plasmids | 1 | 2010 | 343 | 0.320 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2010 | 120 | 0.320 |
Why?
| | Fetal Tissue Transplantation | 4 | 2010 | 34 | 0.310 |
Why?
| | Nerve Growth Factor | 2 | 2006 | 27 | 0.310 |
Why?
| | Tissue Scaffolds | 1 | 2010 | 179 | 0.300 |
Why?
| | Central Nervous System | 1 | 2010 | 230 | 0.300 |
Why?
| | Islets of Langerhans | 2 | 2010 | 728 | 0.290 |
Why?
| | Polyglycolic Acid | 4 | 2012 | 43 | 0.290 |
Why?
| | Stem Cells | 3 | 2010 | 541 | 0.270 |
Why?
| | Polymers | 2 | 2010 | 448 | 0.270 |
Why?
| | Neurites | 2 | 2005 | 43 | 0.250 |
Why?
| | Endothelial Cells | 2 | 2010 | 677 | 0.250 |
Why?
| | Materials Testing | 4 | 2009 | 337 | 0.240 |
Why?
| | Behavior, Animal | 3 | 2016 | 459 | 0.240 |
Why?
| | Retinal Degeneration | 3 | 2010 | 30 | 0.240 |
Why?
| | Glucose | 1 | 2009 | 899 | 0.240 |
Why?
| | Pain | 1 | 2010 | 701 | 0.230 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2005 | 70 | 0.230 |
Why?
| | Retina | 3 | 2010 | 263 | 0.200 |
Why?
| | Choline O-Acetyltransferase | 2 | 1999 | 23 | 0.200 |
Why?
| | Nerve Growth Factors | 2 | 1999 | 70 | 0.200 |
Why?
| | Immunohistochemistry | 3 | 2011 | 1624 | 0.190 |
Why?
| | Cell Count | 3 | 2011 | 303 | 0.190 |
Why?
| | Models, Biological | 2 | 2006 | 1611 | 0.180 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2011 | 16 | 0.180 |
Why?
| | Cell Shape | 2 | 2010 | 54 | 0.170 |
Why?
| | Particle Size | 3 | 2011 | 317 | 0.170 |
Why?
| | Porosity | 2 | 2010 | 88 | 0.160 |
Why?
| | PC12 Cells | 3 | 2009 | 37 | 0.160 |
Why?
| | Cell Aggregation | 3 | 2015 | 24 | 0.160 |
Why?
| | Adenosine Triphosphate | 2 | 2010 | 428 | 0.140 |
Why?
| | Gene Expression Regulation | 3 | 2010 | 2322 | 0.130 |
Why?
| | Stem Cell Transplantation | 2 | 2007 | 148 | 0.130 |
Why?
| | Apoptosis | 3 | 2010 | 2349 | 0.130 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 47 | 0.130 |
Why?
| | Surface Properties | 2 | 2009 | 385 | 0.130 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 18 | 0.120 |
Why?
| | Enzymes | 1 | 2015 | 62 | 0.120 |
Why?
| | Fatigue | 1 | 2016 | 294 | 0.120 |
Why?
| | Cell Size | 2 | 2015 | 79 | 0.110 |
Why?
| | Alzheimer Disease | 2 | 1999 | 442 | 0.100 |
Why?
| | Prosthesis Implantation | 2 | 2011 | 138 | 0.100 |
Why?
| | Parkinson Disease | 1 | 1996 | 345 | 0.100 |
Why?
| | Cell Line | 2 | 2010 | 2629 | 0.100 |
Why?
| | Astrocytes | 2 | 2011 | 159 | 0.100 |
Why?
| | Microglia | 2 | 2011 | 198 | 0.100 |
Why?
| | Dipeptides | 1 | 2011 | 47 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 315 | 0.090 |
Why?
| | Epidermal Growth Factor | 1 | 2011 | 160 | 0.090 |
Why?
| | Proteins | 1 | 1996 | 906 | 0.090 |
Why?
| | Cell Enlargement | 1 | 2010 | 5 | 0.090 |
Why?
| | 3T3 Cells | 1 | 2010 | 140 | 0.090 |
Why?
| | Compressive Strength | 1 | 2010 | 70 | 0.090 |
Why?
| | Molecular Weight | 1 | 2010 | 328 | 0.090 |
Why?
| | Pharmacokinetics | 1 | 2010 | 25 | 0.090 |
Why?
| | Time Factors | 2 | 2010 | 6077 | 0.090 |
Why?
| | Coculture Techniques | 1 | 2010 | 198 | 0.090 |
Why?
| | Polyesters | 1 | 2010 | 64 | 0.080 |
Why?
| | Gels | 1 | 2010 | 72 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 134 | 0.080 |
Why?
| | Insulin | 2 | 2009 | 2080 | 0.080 |
Why?
| | Anxiety | 1 | 2016 | 843 | 0.080 |
Why?
| | Geography | 1 | 2010 | 176 | 0.080 |
Why?
| | Mechanical Phenomena | 1 | 2010 | 80 | 0.080 |
Why?
| | Elastic Modulus | 1 | 2010 | 116 | 0.080 |
Why?
| | Extracellular Matrix | 2 | 2014 | 436 | 0.080 |
Why?
| | Vimentin | 1 | 2009 | 58 | 0.080 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 325 | 0.080 |
Why?
| | Glucose Transporter Type 2 | 1 | 2009 | 10 | 0.080 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 126 | 0.080 |
Why?
| | Esters | 1 | 2009 | 62 | 0.080 |
Why?
| | Cat Diseases | 1 | 2009 | 13 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2010 | 106 | 0.080 |
Why?
| | Absorption | 1 | 2009 | 52 | 0.080 |
Why?
| | Aldehydes | 1 | 2009 | 138 | 0.080 |
Why?
| | Glutathione | 1 | 2010 | 293 | 0.080 |
Why?
| | Plasma | 1 | 2010 | 181 | 0.080 |
Why?
| | Humans | 12 | 2015 | 114049 | 0.080 |
Why?
| | Haplorhini | 1 | 2008 | 57 | 0.070 |
Why?
| | Mice | 4 | 2015 | 14843 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 990 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 58 | 0.070 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 917 | 0.070 |
Why?
| | Mass Spectrometry | 1 | 2009 | 622 | 0.070 |
Why?
| | Growth Substances | 1 | 2006 | 138 | 0.070 |
Why?
| | Nanoparticles | 1 | 2010 | 312 | 0.070 |
Why?
| | Regenerative Medicine | 1 | 2006 | 41 | 0.070 |
Why?
| | Pain Management | 1 | 2009 | 285 | 0.060 |
Why?
| | Diffusion | 1 | 2006 | 119 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1836 | 0.060 |
Why?
| | Fibroblasts | 1 | 2010 | 834 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2007 | 1228 | 0.060 |
Why?
| | Biological Transport | 1 | 2006 | 374 | 0.060 |
Why?
| | Resins, Synthetic | 1 | 2005 | 13 | 0.060 |
Why?
| | Biomimetic Materials | 1 | 2005 | 64 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2010 | 817 | 0.060 |
Why?
| | Cell Communication | 1 | 2006 | 277 | 0.060 |
Why?
| | Cell Lineage | 1 | 2006 | 308 | 0.060 |
Why?
| | Cell Polarity | 1 | 2005 | 131 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2005 | 298 | 0.060 |
Why?
| | Male | 6 | 2016 | 55398 | 0.060 |
Why?
| | Macrophages | 1 | 2010 | 1259 | 0.050 |
Why?
| | Microspheres | 3 | 2010 | 123 | 0.050 |
Why?
| | Evoked Potentials, Visual | 2 | 2010 | 30 | 0.040 |
Why?
| | Biopolymers | 1 | 1999 | 26 | 0.040 |
Why?
| | Drug Implants | 1 | 1999 | 70 | 0.040 |
Why?
| | Cytokines | 1 | 2006 | 1824 | 0.040 |
Why?
| | Superior Colliculi | 2 | 2010 | 33 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 155 | 0.040 |
Why?
| | Biotechnology | 1 | 1999 | 41 | 0.040 |
Why?
| | Electrophysiology | 2 | 2010 | 201 | 0.040 |
Why?
| | Delayed-Action Preparations | 1 | 1999 | 158 | 0.040 |
Why?
| | Animals, Genetically Modified | 2 | 2010 | 215 | 0.040 |
Why?
| | Photic Stimulation | 2 | 2010 | 203 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3254 | 0.040 |
Why?
| | Neurodegenerative Diseases | 1 | 1999 | 92 | 0.040 |
Why?
| | Mathematics | 1 | 1996 | 107 | 0.030 |
Why?
| | Life Expectancy | 1 | 2016 | 46 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2016 | 82 | 0.030 |
Why?
| | Hyperalgesia | 1 | 2016 | 107 | 0.030 |
Why?
| | Polymerization | 1 | 2015 | 119 | 0.030 |
Why?
| | Interpersonal Relations | 1 | 2016 | 338 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2015 | 1075 | 0.020 |
Why?
| | Motor Activity | 1 | 2016 | 635 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 1981 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2783 | 0.020 |
Why?
| | Peptides | 1 | 2015 | 847 | 0.020 |
Why?
| | Cats | 1 | 2009 | 193 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2700 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2007 | 24 | 0.020 |
Why?
| | Head Movements | 1 | 2007 | 17 | 0.020 |
Why?
| | Motion Perception | 1 | 2007 | 13 | 0.020 |
Why?
| | Transcription Factors | 1 | 2015 | 1526 | 0.020 |
Why?
| | Graft Survival | 1 | 2009 | 443 | 0.020 |
Why?
| | Chronic Disease | 1 | 2009 | 1578 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2090 | 0.010 |
Why?
| | Succinimides | 1 | 1999 | 15 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 1999 | 38 | 0.010 |
Why?
| | Fluorescein | 1 | 1999 | 25 | 0.010 |
Why?
| | Dimerization | 1 | 1999 | 176 | 0.010 |
Why?
| | Drug Stability | 1 | 1999 | 151 | 0.010 |
Why?
| | Polyvinyls | 1 | 1999 | 17 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 157 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 1999 | 213 | 0.010 |
Why?
| | Biodegradation, Environmental | 1 | 1999 | 80 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1999 | 241 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 285 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2007 | 3498 | 0.010 |
Why?
| | Drug Carriers | 1 | 1999 | 112 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1999 | 465 | 0.010 |
Why?
| | Kinetics | 1 | 1999 | 1547 | 0.010 |
Why?
| | Female | 2 | 2011 | 59326 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9049 | 0.010 |
Why?
|
|
Mahoney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|